GENEVA, May 15 -- SYNDAX PHARMACEUTICALS, INC. (35 Gatehouse Drive, Building D, Floor 3Waltham, Massachusetts 02451) filed a patent application (PCT/US2024/054432) for "SALTS AND POLYMORPHIC FORMS OF REVUMENIB" on Nov 04, 2024. With publication no. WO/2025/097148, the details related to the patent application was published on May 08, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MAROLEWSKI, Ariane (c/o Syndax Pharmaceuticals, Inc.35 Gatehouse Drive, Building D, Floor 3Waltham, Massachusetts 02451), KATTUBOINA, Venkata A. (c/o Syndax Pharmaceuticals, Inc.35 Gatehouse Drive, Building D, Floo...